Global Cardiac POC Testing Devices Market Size By Type (Troponin test, Brain natriuretic peptide test), By Application (Clinics, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Cardiac POC (Point-of-Care) Testing Devices Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.6 billion by 2031, growing at a CAGR of 10.1% during the forecast period of 2023–2031. This market is witnessing substantial growth driven by the increasing prevalence of cardiovascular diseases (CVDs), the rising need for rapid diagnostics, and the expanding demand for decentralized testing. Cardiac POC devices enable immediate clinical decisions, helping reduce the burden on centralized labs and providing faster treatment initiation, especially in emergency care, ambulances, and remote settings.

Drivers:

1. Rising Global Burden of Cardiovascular Diseases:

CVDs remain the leading cause of death worldwide, necessitating rapid and effective diagnostic tools. The high prevalence of heart attacks, arrhythmias, and heart failure conditions has led to increased adoption of cardiac POC testing devices that allow for immediate troponin, CK-MB, and BNP testing.

2. Shift Towards Decentralized and Home-Based Care:

Healthcare is increasingly moving outside traditional hospital settings. The demand for compact, user-friendly POC devices is surging as more patients seek real-time cardiac health monitoring at clinics, ambulances, or at home.

3. Technological Advancements in Miniaturized and Wireless Devices:

Ongoing innovations in biosensor technology, wireless connectivity, and microfluidics have significantly improved the portability and accuracy of cardiac POC devices. Integration with mobile health apps and cloud-based data sharing further enhances diagnostic capabilities.

Restraints:

1. Regulatory and Reimbursement Challenges:

Stringent regulatory pathways, especially for high-risk cardiac diagnostics, slow down product launches. In addition, inadequate reimbursement frameworks in many countries limit adoption, particularly in cost-sensitive healthcare systems.

2. Limited Sensitivity in Early-Stage Detection:

Although rapid, POC tests may still lag in sensitivity compared to central laboratory systems, particularly in early detection of acute coronary syndromes (ACS), raising concerns among clinicians.

Opportunity:

1. Expansion in Emerging Markets:

Emerging economies in Asia-Pacific and Latin America are investing in rural health infrastructure and emergency response services, creating robust opportunities for POC cardiac diagnostics.

2. Integration with Telemedicine Platforms:

The rise of telemedicine has opened avenues for connected POC testing devices that can transmit real-time cardiac data to physicians for instant consultation, diagnosis, and intervention.

Market by System Type Insights:

The market is segmented into Benchtop Devices and Handheld Devices, with Handheld Devices dominating in 2023 due to their ease of use, portability, and widespread deployment in ambulances, clinics, and remote healthcare facilities. These devices offer rapid biomarker analysis, crucial in time-sensitive cardiac events. However, Benchtop Devices still play a vital role in emergency departments and high-throughput environments.

Market by End-use Insights:

In terms of end-use, Hospitals & Emergency Departments accounted for the largest share in 2023, supported by the urgent need for rapid cardiac diagnostics during acute care. The Ambulatory Surgical Centers (ASCs) & Homecare Settings segment is expected to witness the fastest growth due to growing patient awareness and the availability of user-friendly, connected cardiac POC solutions.

Market by Regional Insights:

North America led the global market in 2023, thanks to robust healthcare infrastructure, high awareness of cardiac health, and strong reimbursement policies. Meanwhile, Asia-Pacific is anticipated to witness the fastest growth, propelled by government-led health screening programs, rapid urbanization, and increased incidence of lifestyle-related cardiac conditions in countries such as China and India.

Competitive Scenario:

Key players in the Global Cardiac POC Testing Devices Market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Instrumentation Laboratory (Werfen), Biosensors International, Nova Biomedical, Alere Inc., and QuidelOrtho Corporation. These companies focus on partnerships, product innovation, and expanding global access.

Key Developments:

In 2023, Abbott introduced an upgraded version of its i-STAT handheld cardiac testing device featuring enhanced connectivity for data integration with EHR systems.

In 2024, Roche Diagnostics expanded its presence in Asia-Pacific with a new cardiac POC production and training center in Singapore.

In 2025, Siemens Healthineers launched a compact POC analyzer integrating troponin and NT-proBNP testing on a single cartridge platform for emergency care settings.

Scope of Work – Global Cardiac POC Testing Devices Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 4.6 billion

CAGR (2023–2031) 10.1%

Key Segments System Type (Handheld, Benchtop), End-use (Hospitals, ASCs, Homecare)

Growth Drivers Prevalence of cardiovascular diseases, demand for rapid diagnostics

Opportunities Expansion in emerging markets, telemedicine integration

FAQs:

1) What is the current market size of the Global Cardiac POC Testing Devices Market?

The Global Cardiac POC Testing Devices Market was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Cardiac POC Testing Devices Market?

The major growth driver is the rising global burden of cardiovascular diseases and the need for rapid, point-of-care diagnostics.

3) Which is the largest region during the forecast period in the Global Cardiac POC Testing Devices Market?

North America is projected to remain the largest region due to advanced healthcare infrastructure and strong adoption rates.

4) Which segment accounted for the largest market share in the Global Cardiac POC Testing Devices Market?

The Hospitals & Emergency Departments segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Cardiac POC Testing Devices Market?

Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Instrumentation Laboratory (Werfen).

Would you like a visual chart or infographic to accompany this report?